Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients
No Thumbnail Available
Identifiers
Date
2019-10-01
Authors
Laza-Briviesca, R.
Cruz-Bermudez, A.
Casarrubios, M.
Nadal, E.
Insa, A.
Garcia Campelo, R.
De Dios Alvarez, N.
Domine, M.
Majem, M.
Rodriguez-Abreu, D.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
Abstract
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
stage IIIA NSCLC, biomarkers, neo-adjuvant chemo-immunotherapy